跳至主要内容
临床试验/CTRI/2025/07/091698
CTRI/2025/07/091698尚未招募不适用

Validation of a heart health monitoring device in individuals with and without cardiovascular risk factors

Connected Health, TATA Industries Limited1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年8月18日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
150
试验地点
1
主要终点
Correlation between heart rate HR ECG parameters blood pressure variation and oxygen saturation SpOtwo values obtained using the heart health monitoring device and gold standard methods such as 12-lead ECG

研究概览

简要总结

This study aims to assess the performance of the heart health monitoring device in individuals with and without cardiovascular risk factors by comparing the results with Gold standards

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Consenting adults of any gender in 3 categories with 50:50 ratio of males and females who fulfils atleast one of the following criteria a.
  • Healthy individuals with no risk for CVD b.
  • Patients with risk for CVD (DM, HT, dyslip) without a CVD event (stroke, MI, HF, PAD) c.
  • Patients who had a vascular event (MI or stroke) in the last one year.

排除标准

  • a.Critically ill patients b.
  • Patients with cognitive impairment.
  • Patients and volunteers above 65 years age.
  • Pregnant and Lactating women.

结局指标

主要结局

Correlation between heart rate HR ECG parameters blood pressure variation and oxygen saturation SpOtwo values obtained using the heart health monitoring device and gold standard methods such as 12-lead ECG

时间窗: At baseline

次要结局

  • Consistency of the devices readings across repeated measurements within the same individual under similar conditions Intraclass correlation coefficients for assessing reliability(At Baseline)

研究者

发起方
Connected Health, TATA Industries Limited
申办方类型
Other []
责任方
Principal Investigator
主要研究者

Dr Denis Xavier

St. Johns Health Innovation Foundation

研究点 (1)

Loading locations...

相似试验